Imiquimod Cream
Product Images NDC 51672-4174

10 FDA label images from Sun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Imiquimod (NDC 51672-4174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table-2 (Table 2.)

Table-2 (Table 2.)
A table comparing percentages of various skin reactions and their severity among groups treated with Imiquimod Cream 3.75%, Imiquimod Cream 2.5%, and a Vehicle control. Reactions include erythema, scabbing/crusting, flaking/scaling/dryness, edema, erosion/ulceration, and exudate, with data split into all grades and severe cases for each reaction.*
FDA Label Image

Table-3 (Table 3.)

Table-3 (Table 3.)
Table presenting adverse reactions comparing Imiquimod Cream 3.75% (N=400) and Vehicle (N=202). It includes frequency data for application site pain, irritation, pruritus, bacterial vaginitis, and headache, with respective percentages for each treatment group.*
FDA Label Image

Table-4 (Table 4.)

Table-4 (Table 4.)
A table comparing the percentage of patients experiencing various skin reactions of all grades and severe grades between Imiquimod cream 3.75% (N=400) and vehicle (N=202). The table lists erythema, edema, erosion/ulceration, and exudate with associated percentages for both treatment groups.*
FDA Label Image

Chemical Structure (Imiquimod 01)

Chemical Structure (Imiquimod 01)
Chemical structure of Imiquimod, showing its molecular arrangement with nitrogen and carbon atoms including a substituted imidazoquinoline framework.*
FDA Label Image

Figure 1 (Imiquimod 02)

Figure 1 (Imiquimod 02)
A line graph showing cumulative complete clearance over time (weeks) comparing Imiquimod 3.75% cream to vehicle. The graph illustrates an increasing clearance trend for Imiquimod 3.75% over 16 weeks, while the vehicle shows a relatively flat clearance rate.*
FDA Label Image

Image (Imiquimod 03)

Image (Imiquimod 03)
An instructional line drawing showing a hand holding a small tube, likely demonstrating how to hold or apply a topical cream product. No text or product branding is visible on the tube.*
FDA Label Image

Principal Display Panel (28 Packet Carton)

Principal Display Panel (28 Packet Carton)
Imiquimod Cream USP 3.75% packaging label for topical use, containing 28 single-use packets each with 0.25 g (net 7 g per box). Label includes NDC 51672-4174-6, manufacturer Taro Pharmaceutical Industries Ltd., and distributor Taro Pharmaceuticals U.S.A., Inc. Warnings emphasize keeping medication out of children's reach, and it is marked Rx only.*
FDA Label Image

Carton Label (Packet Carton Label)

Carton Label (Packet Carton Label)
Packaging label for Imiquimod Cream USP 3.75% topical cream, distributed by Sun Pharmaceutical Industries, Inc. The label shows the product name prominently with strength, and states it is for topical use only. The box contains 28 single-use packets, each with a net weight of 0.25 g, with 7 g total net weight per box. The label includes storage instructions, a barcode, and manufacturer details. Warnings about keeping the product out of reach of children and usage restrictions are also visible.*
FDA Label Image

Principal Display Panel (7.5 g Bottle Carton)

Principal Display Panel (7.5 g Bottle Carton)
Packaging label for Imiquimod Cream USP 3.75% Pump, 7.5 g, a topical prescription drug by Sun Pharmaceutical Industries, Inc. The label includes storage instructions, active ingredient content, warnings against ophthalmic, oral, or intravaginal use, and manufacturer details. The product is distributed by Taro Pharmaceuticals U.S.A., with instructions to store upright and keep out of children's reach.*
FDA Label Image

Carton Label (Pump Carton Label)

Carton Label (Pump Carton Label)
Imiquimod Cream USP 3.75% pump packaging label showing a net weight of 7.5 g. The label highlights topical use only and cautions against ophthalmic, oral, or intravaginal use. Manufacturer is Taro Pharmaceutical Industries Ltd., with distribution by Sun Pharmaceutical Industries, Inc. The label includes storage instructions and a list of inactive ingredients. NDC 51672-4174-9 is displayed along with the Sun Pharma logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.